Rare Diseases and Orphan Products Breakthrough Summit

NORD’s Rare Diseases and Orphan Products Breakthrough Summit is the largest and most meaningful multistakeholder event of its kind – Powered by over 30 years of passion and serving the patients and families affected by rare diseases with new channels of answers, advocacy, advancements in research and access to life-transforming treatments.  The 2014 Breakthrough Summit is concentrated with innovative content and convenes the top leaders from the FDA, NIH, Industry, Patient Groups, Payers and Research Institutions to address the progress of rare disease diagnosis, genomics, drug development, patient engagement, product approvals, FDA oversight and market accessibility to orphan products. 

Expecting an unprecedented turnout, the NORD 2014 Breakthrough Summit is crafted with multiple workshops and focused tracks of content to ensure high quality learning, networking and accessibility to thought leaders in the rare disease community.

  • Network, learn and benchmark from hundreds of industry counterparts, patient advocacy stakeholders, investors and FDA leadership to better align their thinking on complex issues
  • Gain insight into the strategic models for commercializing an orphan product
  • Learn strategies to stay ahead of the curve on the newest R&D advancements in rare diagnostics and treatment regimens
Advantage Pricing Expires August 15, 2014


Margaret A. Hamburg, MD, Commissioner

U.S. Food and Drug Administration

Janet Woodcock, MD, Director

Center for Drug Evaluation & Research

U.S. Food and Drug Administration


Meeting Venue:

Hilton Alexandria Mark Center

5000 Seminary Road

Alexandria, VA 22311

Be engaged!

For Speaking Opportunities, please contact:  [email protected]

For Scholarship Opportunities, please contact: [email protected]

For Sponsorship Opportunities, please contact: [email protected]